Sign in and upgrade to a paid plan to export announcements as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.

CORONA Remedies Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: CORONA BSE: 544644

About CORONA Remedies Limited

No company profile on record yet.

Key facts

BSE symbol544644
NSE symbolCORONA
ISININE02ZQ01018
CINL24231GJ2004PLC044656
Listing date15 Dec 2025
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorM/s. Dhara Patel (Dhara Panara)
Registered officeCORONA House, C-Mondeal Business Park, Near Gurudwara, S.G. Highway, Thaltej, Ahmedabad - 380059, Gujarat, India

Financial performance

Full financials →
Fiscal yearMar 26
Total income (before exceptional items)—
Net profit185

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Ankur Kirtikumar MehtaExecutive DirectorJune 30, 2026
Niravkumar Kirtikumar MehtaExecutive DirectorJune 30, 2026
Viral Bhupendrabhai SitwalaExecutive DirectorJune 30, 2026
Ameetkumar Hiranyakumar DesaiIndependent DirectorJune 30, 2026
Bhaskar Vemban IyerIndependent DirectorJune 30, 2026
Monica Hemal KanugaIndependent DirectorJune 30, 2026
Shirish Gundopant BelapureIndependent DirectorJune 30, 2026
Kirtikumar Laxmidas MehtaNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.